Lansoprazol Sun

Lansoprazole, the active ingredient in Lansoprazol Sun, is a proton pump inhibitor presented as a tablet for oral use. It reduces gastric acid secretion and is used to treat gastro‑esophageal reflux disease, erosive esophagitis, peptic ulcer disease and as part of Helicobacter pylori eradication regimens in adults.

GNH USA supplies Lansoprazol Sun as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lansoprazole, a proton pump inhibitor, is employed to lower gastric acidity in several acid‑related disorders. - Gastro‑esophageal reflux disease (GERD): alleviates heartburn and reflux symptoms by reducing acid exposure. - Erosive esophagitis: promotes healing of inflamed esophageal tissue. - Peptic ulcer disease: supports ulcer healing and prevents recurrence. - Helicobacter pylori eradication (in combination therapy): enhances eradication rates when used with antibiotics and a bismuth compound.

Lansoprazole may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhea: loose stools, usually self‑limiting. - Nausea: occasional upset stomach. - Abdominal pain: cramping or discomfort. - Flatulence: increased intestinal gas. - Constipation: reduced bowel movements.

Serious or Rare Side Effects: - Severe allergic reaction: rash, itching, swelling, or difficulty breathing. - Clostridioides difficile infection: persistent diarrhea with abdominal pain. - Low magnesium levels: muscle cramps, weakness, or irregular heartbeat. - Vitamin B12 deficiency: fatigue, neuropathy with long‑term use. - Bone fractures: increased risk with prolonged therapy. - Acute interstitial nephritis: kidney inflammation presenting with fever and urinary changes.

Before initiating therapy, consider patient‑specific factors and monitor for potential risks. - Assess renal and hepatic function: dose adjustment may be needed in impairment. - Review concomitant medications: potential for drug‑drug interactions. - Use the lowest effective dose: limit duration to the shortest period necessary. - Pregnancy and lactation: discuss risks and benefits with a healthcare professional. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Lansoprazole can affect the absorption and metabolism of several co‑administered drugs.

Major Interactions (Avoid): - Antiretroviral protease inhibitors (e.g., atazanavir): reduced efficacy. - Antifungal agents (e.g., ketoconazole, itraconazole): decreased absorption. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR, monitor coagulation. - Methotrexate: increased serum levels, watch for toxicity. - Digoxin: altered plasma concentration, assess clinical response. - Iron supplements: reduced absorption, separate dosing by at least 2 hours.